Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

This entry reports the completion of a phase 1/2 trial evaluating a monoclonal antibody therapy in patients with advanced colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Monoclonal antibody therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED